Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

Cited by (1,015)

Items 301–400 of 1,015

1. A mathematical model of ctDNA shedding predicts tumor detection size
   Stefano Avanzini, David Matthew Kurtz, Jacob J. Chabon, Everett James Moding, Sharon Seiko Hori, Sanjiv Sam Gambhir, Ash A. Alizadeh, Maximilian Diehn, Johannes G. Reiter · 2020 · Science Advances
2. An emerging role of microplastics in the etiology of lung ground glass nodules
   Qiqing Chen, Jiani Gao, Hairui Yu, Hang Su, Yan T. Yang, Yajuan Cao, Qun Zhang, Yijiu Ren, Henner Hollert, Huahong Shi et al. · 2022 · Environmental Sciences Europe
3. Tobacco and Lung Cancer: Risks, Trends, and Outcomes in Patients with Cancer
   Graham Walter Warren, K. Michael Cummings · 2013 · American Society of Clinical Oncology Educational Book
4. The State of Molecular Biomarkers for the Early Detection of Lung Cancer
   Mohamed Hassanein, J. Clay Callison, Carol Callaway‐Lane, Melinda C. Aldrich, Eric L. Grogan, Pierre P. Massion · 2012 · Cancer Prevention Research
5. Synthetic biomarkers: a twenty-first century path to early cancer detection
   Gabriel A. Kwong, Sharmistha Ghosh, Lena Gamboa, Christos Patriotis, Sudhir Srivastava, Sangeeta N. Bhatia · 2021 · Nature reviews. Cancer
6. Artificial intelligence: A critical review of applications for lung nodule and lung cancer
   Constance de Margerie‐Mellon, Guillaume Chassagnon · 2022 · Diagnostic and Interventional Imaging
7. Radiomics and artificial intelligence for precision medicine in lung cancer treatment
   Mitchell Chen, Susan Jennifer Copley, Patrizia Viola, Haonan Lu, Eric Ofori Aboagye · 2023 · Seminars in Cancer Biology
8. Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004–2009
   Keisha A. Houston, S. Jane Henley, Jun Li, Mary C. White, Thomas B. Richards · 2014 · Lung Cancer
9. Disparities in Lung Cancer Screening: A Review
   Diane N. Haddad, Kim Lori Sandler, Louise M. Henderson, M. Patricia Rivera, Melinda C. Aldrich · 2020 · Annals of the American Thoracic Society
10. DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types
    Vera Constâncio, Sandra P. Nunes, Rui Henrique, Cármen Jerónimo · 2020 · Cells
11. Current Challenges in Volatile Organic Compounds Analysis as Potential Biomarkers of Cancer
    Kamila Schmidt, Ian D. Podmore · 2015 · Journal of Biomarkers
12. External validation of a convolutional neural network artificial intelligence tool to predict malignancy in pulmonary nodules
    David Baldwin, Jennifer K. Gustafson, L. Pickup, Carlos Arteta, Petr Novotný, Jerome M. Declerck, Timor Kadir, Catarina Figueiras, Albert Sterba, Alan Exell et al. · 2020 · Thorax
13. Lifetime Smoking History and Risk of Lung Cancer: Results From the Framingham Heart Study
    Hilary Aurora Tindle, Meredith Stevenson, Robert A. Greevy, Ramachandran Srini Vasan, Suman Kundu, Pierre P. Massion, Matthew S. Freiberg · 2018 · JNCI Journal of the National Cancer Institute
14. Deep Learning for Lung Cancer Nodules Detection and Classification in CT Scans
    Diego Riquelme, Moulay A. Akhloufi · 2020 · AI
15. Update 2025: Management of Non‑Small-Cell Lung Cancer
    Hyein Jeon, Shuai Wang, Junmin Song, Harjot Gill, Haiying Cheng · 2025 · Lung
16. Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non–Small-Cell Lung Cancer: A Competing Risks Analysis
    Takashi Eguchi, Sarina Bains, Ming-Ching Lee, Kay See Tan, Boris D. Hristov, Daniel Buitrago, Manjit S. Bains, Robert J. Downey, James Guoxian Huang, James M. Isbell et al. · 2016 · Journal of Clinical Oncology
17. Artificial intelligence applications for thoracic imaging
    Guillaume Chassagnon, Maria Vakalopoulou, Nikos Paragios A, Marie‐Pierre Revel · 2019 · European Journal of Radiology
18. One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study
    Ni Li, Fengwei Tan, Wanqing Chen, Min Dai, Fei Wang, Sipeng Shen, Wei Tang, Jiang Li, Yiwen Yu, Wei Cao et al. · 2022 · The Lancet Respiratory Medicine
19. Components Necessary for High-Quality Lung Cancer Screening
    Peter J. Mazzone, Charles A. Powell, Douglas A. Arenberg, Peter Brian Bach, Frank C. Detterbeck, Michael K. Gould, Michael T. Jaklitsch, James R. Jett, David P. Naidich, Anil Vachani et al. · 2014 · CHEST Journal
20. Clinical Impact of Immune Microenvironment in Stage I Lung Adenocarcinoma: Tumor Interleukin-12 Receptor β2 (IL-12Rβ2), IL-7R, and Stromal FoxP3/CD3 Ratio Are Independent Predictors of Recurrence
    Kei Suzuki, Kyuichi Kadota, Camelia S. Sima, Jun‐ichi Nitadori, Valerie W. Rusch, William David Travis, Michel Sadelain, Prasad S. Adusumilli · 2012 · Journal of Clinical Oncology
21. Increased risk of lung cancer in individuals with a family history of the disease: A pooled analysis from the International Lung Cancer Consortium
    Michele L. Coté, Mei Liu, Stefano Bonassi, Monica Neri, Ann G. Schwartz, David C. Christiani, Margaret R. Spitz, Joshua E. Muscat, Gad Rennert, Katja K.H. Aben et al. · 2012 · European Journal of Cancer
22. The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial
    Nichole T. Tanner, Neeti M. Kanodra, Mulugeta Gebregziabher, Elizabeth Payne, Chanita Hughes Halbert, Graham Walter Warren, Leonard E. Egede, Gerard A. Silvestri · 2015 · American Journal of Respiratory and Critical Care Medicine
23. Lung nodules: size still matters
    Anna Rita Larici, Alessandra Farchione, Paola Franchi, Mario Ciliberto, Giuseppe Cicchetti, Lucio Calandriello, Annemilia del Ciello, Lorenzo Bonomo · 2017 · European Respiratory Review
24. Drinking Water Arsenic in Northern Chile: High Cancer Risks 40 Years after Exposure Cessation
    Craig Steinmaus, Catterina Ferreccio R, Johanna Acevedo Romo, Yan Yuan A, Sandra Cortés, Guillermo Marshall, Lee E. Moore, John Randolph Balmes, Jane Liaw, Todd Rabkin Golden et al. · 2013 · Cancer Epidemiology Biomarkers & Prevention
25. Annual number of lung cancer deaths potentially avertable by screening in the United States
    Jiemin Ma, Elizabeth Ward, Robert Allen Smith, Ahmedin Jemal · 2013 · Cancer
26. VATS Lobectomy Has Better Perioperative Outcomes Than Open Lobectomy: CALGB 31001, an Ancillary Analysis of CALGB 140202 (Alliance)
    Chukwumere E. Nwogu, Jonathan D’Cunha, Herbert Pang, Lin Gu, Xiaofei Wang, William G. Richards, Linda J. Veit, Todd L. Demmy, David J. Sugarbaker, Leslie J. Kohman et al. · 2014 · The Annals of Thoracic Surgery
27. The diagnosis and treatment of COPD and its comorbidities
    Kathrin Kahnert, Rudolf A. Jörres, Jürgen Behr, Tobias Welte · 2023 · Deutsches Ärzteblatt international
28. A survey of computer-aided diagnosis of lung nodules from CT scans using deep learning
    Yu Gu, Jingqian Chi, Jiaqi Liu, Lidong Yang, Baohua Zhang, Dahua Yu, Ying Zhao, Xiaoqi Lu · 2021 · Computers in Biology and Medicine
29. Definition of a Positive Test Result in Computed Tomography Screening for Lung Cancer
    Claudia I. Henschke, Rowena Yip, David F. Yankelevitz, James P. Smith, for the International Early Lung Cancer Action Program Investigators* · 2013 · Annals of Internal Medicine
30. PD‐L1 expression in non‐small cell lung carcinoma: Comparison among cytology, small biopsy, and surgical resection specimens
    Jonas J. Heymann, William A. Bulman, David Swinarski, Carlos A. Pagan, John P. Crapanzano, Mehrvash Haghighi, Ladan Fazlollahi, Mark B. Stoopler, Joshua R. Sonett, Adrian G. Sacher et al. · 2017 · Cancer Cytopathology
31. Cancer screening in the United States, 2012
    Robert Allen Smith, Vilma E. Cokkinides, Otis Webb Brawley · 2012 · CA A Cancer Journal for Clinicians
32. Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline
    Bryan James Schneider, Nofisat Ismaila, Joachim G.J.V. Aerts, Caroline Chiles, Megan Eileen Daly, Frank C. Detterbeck, Jason W.D. Hearn, Sharyn I. Katz, Natasha B. Leighl, Benjamin Philip Levy et al. · 2019 · Journal of Clinical Oncology
33. Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitors
    Puey Ling Chia, Thomas John, Alexander Dobrovic, Paul L R Mitchell · 2014 · Clinical Epidemiology
34. Clinical and Organizational Factors in the Initial Evaluation of Patients With Lung Cancer
    David E. Ost, Sai‐Ching J. Yeung, Lynn T. Tanoue, Michael K. Gould · 2013 · CHEST Journal
35. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma
    Chao Zhang, Jianjun J. Zhang, Fang-Ping Xu, Yin-Guang Wang, Zhi Xie, Jian Su, Song Dong, Qiang Nie, Yang Washington Shao, Qing Hua Zhou et al. · 2019 · Journal of Thoracic Oncology
36. Health-related quality of life after surgical treatment in patients with non-small cell lung cancer: a systematic review
    Poghosyan, Hermine, Sheldon, Lisa Kennedy, Leveille, Suzanne G., Cooley, Mary E. · 2013 · Lung Cancer
37. Air Pollution and Lung Cancer: A Review by International Association for the Study of Lung Cancer Early Detection and Screening Committee
    Christine D. Berg, Joan H. Schiller, Paolo Boffetta, Jing Cai, Casey Connolly, Anna Kerpel-Fronius, Andrea Borondy Kitts, David Chi-Leung Lam, Anant Mohan, Renelle L. Myers et al. · 2023 · Journal of Thoracic Oncology
38. Accuracy of FDG-PET to Diagnose Lung Cancer in Areas With Infectious Lung Disease
    Stephen A. Deppen, Jeffrey D. Blume, Clark D. Kensinger, Ashley M. Morgan, Melinda C. Aldrich, Pierre P. Massion, Ronald C. Walker, Melissa L McPheeters, Joe Bill Putnam, Eric L. Grogan · 2014 · JAMA
39. Artificial Intelligence in Oncology: Current Landscape, Challenges, and Future Directions
    Lotter, William, Hassett, Michael J., Schultz, Nikolaus, Kehl, Kenneth L., Van Allen, Eliezer M., Cerami, Ethan · 2024 · Cancer Discovery
40. Preoperative computed tomography–guided microcoil localization of small peripheral pulmonary nodules: A prospective randomized controlled trial
    Richard J. Finley, John Robert Mayo, Kyle Grant, Joanne C. Clifton, John C. English, Joyce M. Leo, Stephen C. Lam · 2014 · Journal of Thoracic and Cardiovascular Surgery
41. Barriers to Lung Cancer Screening Engagement from the Patient and Provider Perspective
    Gary X. Wang, Travis P. Baggett, Pari V. Pandharipande, Elyse Richelle Park, Sanja Percac‐Lima, Jo-Anne O. Shepard, Florian Johannes Fintelmann, Efrén J. Flores · 2019 · Radiology
42. Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood
    Maryam A Aleissa, Lane Lerner, Eihab Abdelfatah, Nakul Shankar, Joseph K. Canner, Nesrin M. Hasan, Vesal Yaghoobi, Barry Huang, Zachary J. Kerner, Felipe Takaesu et al. · 2019 · Clinical Epigenetics
43. First Human Use of a New Robotic-Assisted Fiber Optic Sensing Navigation System for Small Peripheral Pulmonary Nodules
    David I. Fielding, Farzad Bashirzadeh, Jung Hwa Son, Maryann Todman, Adrian Chin, Lionel Tan, Karin Steinke, Morgan N. Windsor, Arthur Wai Sung · 2019 · Respiration
44. A Review of Deep Learning Techniques for Lung Cancer Screening and Diagnosis Based on CT Images
    Mohammad A. Thanoon, Mohd Asyraf Zulkifley, Muhammad Ammirrul Atiqi Mohd Zainuri, Siti Raihanah Abdani · 2023 · Diagnostics
45. Non-invasive Breath Analysis of Pulmonary Nodules
    Nir Peled, Meggie Hakim, Paul A. Bunn, York E. Miller, Timothy C. Kennedy, Jane Mattei, John D. Mitchell, Fred R. Hirsch, Hossam Haick · 2012 · Journal of Thoracic Oncology
46. Audit of the autoantibody test, EarlyCDT®-Lung, in 1600 patients: An evaluation of its performance in routine clinical practice
    James R. Jett, Laura J. Peek, Lynn Fredericks, William R. Jewell, William W. Pingleton, John F.R. Robertson · 2013 · Lung Cancer
47. Calcified Atherosclerosis in Different Vascular Beds and the Risk of Mortality
    Matthew Allison, Stephanie Hsi, Christina L. Wassel, Cindy G. Morgan, Joachim H. Ix, Michael H. Criqui, Michael H. Criqui · 2011 · Arteriosclerosis Thrombosis and Vascular Biology
48. Lung Cancer Detection: A Deep Learning Approach
    Siddharth Bhatia, Yash Sinha, Lavika Goel · 2018 · Advances in intelligent systems and computing
49. Machine Learning for Early Lung Cancer Identification Using Routine Clinical and Laboratory Data
    Michael K. Gould, Brian Z. Huang, Martin Carl Tammemägi, Yaron Kinar, Ron Shiff · 2021 · American Journal of Respiratory and Critical Care Medicine
50. Recommendations on screening for lung cancer
    Canadian Task Force on Preventive Health Care · 2016 · Canadian Medical Association Journal
51. Long-Term Prognosis of Patients With Resected Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma of the Lung
    Masaya Yotsukura, Hisao Asamura, Noriko Motoi, Jumpei Kashima, Yukihiro Yoshida, Kazuo Nakagawa, Kouya Shiraishi, Takashi Kohno, Yasushi Yatabe, Shun-ichi J. WATANABE · 2021 · Journal of Thoracic Oncology
52. Noninvasive Urinary Metabolomic Profiling Identifies Diagnostic and Prognostic Markers in Lung Cancer
    Ewy A. Mathé, Andrew D. Patterson, Majda Haznadar, Soumen Manna, Kristopher W. Krausz, Elise D. Bowman, Peter G. Shields, Jeffrey R. Idle, Philip B. W. Smith, Katsuhiro Anami et al. · 2014 · Cancer Research
53. MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
    Martin Pichler, George A. Călin · 2015 · British Journal of Cancer
54. Missed lung cancer: when, where, and why?
    Annemilia del Ciello, Paola Franchi, Andrea Contegiacomo, Giuseppe Cicchetti, Lorenzo Bonomo, Anna Rita Larici · 2017 · Diagnostic and Interventional Radiology
55. Pulmonary Perifissural Nodules on CT Scans: Rapid Growth Is Not a Predictor of Malignancy
    Bartjan de Hoop, Bram van Ginneken, Hester A. Gietema, Mathias Prokop · 2012 · Radiology
56. Lung cancer screening: what do long‐term smokers know and believe?
    Lisa Carter‐Harris, DuyKhanh P. Ceppa, Nasser H. Hanna, Susan M. Rawl · 2015 · Health Expectations
57. Pan-cancer analysis demonstrates that integrating polygenic risk scores with modifiable risk factors improves risk prediction
    Linda Kachuri, Rebecca E. Graff, Karl Smith-Byrne, Travis J. Meyers, Sara R. Rashkin, Elad Ziv, John S. Witte, Mattias Johansson · 2020 · Nature Communications
58. Assessing the accuracy of a deep learning method to risk stratify indeterminate pulmonary nodules
    Massion, Pierre P., Antic, Sanja, Ather, Sarim, Arteta, Carlos, Brabec, Jan, Chen, Heidi, Declerck, Jerome, Dufek, David, Hickes, William, Kadir, Timor et al. · 2020 · American Journal of Respiratory and Critical Care Medicine
59. Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer
    Rafael Molina, Ramón María Marrades, Josep Maria Auge, José Miguel Escudero Fernández, Núria Viñolas, Noemı́ Reguart, José Ramírez, Xavier Filella, Laureano Molins, Alvar G.N. Agustí · 2015 · American Journal of Respiratory and Critical Care Medicine
60. Validation of the SHOX2 / PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease
    Günter Weiss, Anne Schlegel, Denise Kottwitz, Thomas König, Reimo Tetzner · 2016 · Journal of Thoracic Oncology
61. Lung Cancer Screening Utilization: A Behavioral Risk Factor Surveillance System Analysis
    Whitney E. Zahnd, Jan Marie Eberth · 2019 · American Journal of Preventive Medicine
62. Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study
    Gee‐Chen Chang, Chao‐Hua Chiu, Chong‐Jen Yu, Yeun‐Chung Chang, Ya-Hsuan Chang, Kuo-Hsuan Hsu, Yu‐Chung Wu, Chih-Yi Chen, Hsian‐He Hsu, Ming‐Ting Wu et al. · 2023 · The Lancet Respiratory Medicine
63. A survey on deep learning in medical image registration: New technologies, uncertainty, evaluation metrics, and beyond
    Junyu Chen, Yihao Liu, Shuwen Wei, Zhangxing Bian, Shalini Subramanian, Aaron Carass, Jerry L. Prince, Yong Du · 2024 · Medical Image Analysis
64. Primary Care Provider-Delivered Smoking Cessation Interventions and Smoking Cessation Among Participants in the National Lung Screening Trial
    Elyse Richelle Park, Ilana F. Gareen, Sandra J. Japuntich, Inga Tolin Lennes, Kelly A. Hyland, Sarah DeMello, JoRean D. Sicks, Nancy A. Rigotti · 2015 · JAMA Internal Medicine
65. Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round
    Nikolaus Becker, Erna Motsch, M.-L. Gross, A. Eigentopf, Claus Peter Heußel, Hendrik Dienemann, Ph. A. Schnabel, Lothar Richard Pilz, Monika Eichinger, D.-E. Optazaite et al. · 2012 · Journal of Cancer Research and Clinical Oncology
66. EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays
    Caroline J Chapman, Graham F. Healey, Andrea Murray, Peter Boyle, Chris Robertson, Laura J. Peek, Jared Allen, Alison J. Thorpe, Geoffrey Hamilton-Fairley, Celine B. Parsy-Kowalska et al. · 2012 · Tumor Biology
67. Patient Adherence to Screening for Lung Cancer in the US
    Maria Angeles Lopez-Olivo, Kristin G. Maki, Noah J. Choi, Richard M. Hoffman, Ya‐Chen Tina Shih, Lisa M. Lowenstein, Rachel Hicklen, Robert Joseph Volk · 2020 · JAMA Network Open
68. Environmental and occupational determinants of lung cancer
    Abhishek Shankar, Anusha Dubey, Deepak Saini, Mayank Kumar Singh, Chandra Prakash Prasad, Shubham Roy, Sachidanand Jee Bharati, Rinki Minakshi, Navneet Singh, Tulika Seth et al. · 2019 · Translational Lung Cancer Research
69. Variability and Standardization of Quantitative Imaging
    Akifumi Hagiwara, Shohei Fujita, Yoshiharu Ohno, Shigeki Aoki · 2020 · Investigative Radiology
70. Low‐dose computed tomography lung cancer screening: Clinical evidence and implementation research
    Harriet L Lancaster, Marjolein A. Heuvelmans, Matthijs Oudkerk · 2022 · Journal of Internal Medicine
71. International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 Report
    John K. Field, Robert Allen Smith, Denise R. Aberle, Matthijs Oudkerk, David Baldwin, David F. Yankelevitz, Jesper Holst Pedersen, Steven Swanson, William David Travis, Ignacio I. Wisbuba et al. · 2011 · Journal of Thoracic Oncology
72. International Variation in Lung Cancer Mortality Rates and Trends among Women
    Lindsey A. Torre, Rebecca L. Siegel, Elizabeth Ward, Ahmedin Jemal · 2014 · Cancer Epidemiology Biomarkers & Prevention
73. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial
    Edward F. Patz, Erin M. Greco, Constantine A. Gatsonis, Paul F. Pinsky, Barnett S. Kramer, Denise R. Aberle · 2016 · The Lancet Oncology
74. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
    Lynn T. Tanoue · 2012 · Yearbook of Medicine
75. Critical Review of Volatile Organic Compound Analysis in Breath and In Vitro Cell Culture for Detection of Lung Cancer
    Zhunan Jia, Abhijeet Patra, Viknish Krishnan‐Kutty, Thirumalai Venkatesan · 2019 · Metabolites
76. ACR Lung-RADS v2022: Assessment Categories and Management Recommendations
    Jared D. Christensen, Ashley Elizabeth Prosper, Carol C. Wu, Jonathan Hero Chung, Elizabeth Lee, Brett M. Elicker, Andetta R. Hunsaker, Milena Petranović, Kim Lori Sandler, Brendon Matthew Stiles et al. · 2023 · Journal of the American College of Radiology
77. Increased Lung and Bladder Cancer Incidence in Adults after In Utero and Early-Life Arsenic Exposure
    Craig Steinmaus, Catterina Ferreccio R, Johanna Acevedo, Yan Yuan A, Jane Liaw, Viviana Durán, Susana Cuevas, José García, Rodrigo Meza, Rodrigo Valdés et al. · 2014 · Cancer Epidemiology Biomarkers & Prevention
78. Clinicopathologic Features of Advanced Squamous NSCLC
    Mark A. Socinski, Coleman K. Obasaju, David R. Gandara, Fred R. Hirsch, Philip Bonomi, Paul A. Bunn, Edward S. Kim, Corey Jay Langer, Ronald B. Natale, Silvia Novello et al. · 2016 · Journal of Thoracic Oncology
79. Lung nodules: A comprehensive review on current approach and management
    Mina Gaga, Konstantinos Loverdos, Andreas Photiades, Chrysoula Kontogianni, Marianthi P. Iliopoulou · 2019 · Annals of Thoracic Medicine
80. Management of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology
    Athanasios G. Pallis, Cesare Gridelli, Ulrich Wedding, Corinne Faivre Finn, Giulia Veronesi, Michael T. Jaklitsch, Andrea Luciani, Mary E.R. O'Brien · 2014 · Annals of Oncology
81. Multilevel Opportunities to Address Lung Cancer Stigma across the Cancer Control Continuum
    Heidi A. Hamann, Elizabeth S. Ver Hoeve, Lisa Carter‐Harris, Jamie L. Studts, Jamie S. Ostroff · 2018 · Journal of Thoracic Oncology
82. Deep Learning for Malignancy Risk Estimation of Pulmonary Nodules Detected at Low-Dose Screening CT
    Kiran Vaidhya Venkadesh, Arnaud A. A. Setio, Anton Schreuder, Ernst T. Scholten, Kaman Chung, Mathilde Marie Winkler Wille, Zaigham Saghir, Bram van Ginneken, Mathias Prokop, Colin Jacobs · 2021 · Radiology
83. The Microbiome in Lung Cancer Tissue and Recurrence-Free Survival
    Peters, Brandilyn A., Hayes, Richard B., Goparaju, Chandra, Reid, Christopher, Pass, Harvey I., Ahn, Jiyoung · 2019 · Cancer Epidemiology, Biomarkers & Prevention
84. Head and Neck Cancer Survivorship Care Guideline: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Cancer Society Guideline
    Larissa Nekhlyudov, Christina Lacchetti, Nancy B. Davis, Thomas Q. Garvey, David Paul Goldstein, Johannes C. Nunnink, Jose Ignacio Ruades Ninfea, Andrew Salner, Talya Salz, Lillian L. Siu · 2017 · Journal of Clinical Oncology
85. Lung nodule detection in CT using 3D convolutional neural networks
    Xiaojie Huang, Junjie Shan, Vivek Vaidya · 2017 · IEEE International Symposium on Biomedical Imaging (ISBI)
86. Pulmonary nodule detection in CT scans with equivariant CNNs
    Marysia Winkels, Taco Cohen · 2019 · Medical Image Analysis
87. Surgery versus stereotactic body radiation therapy for stage I non–small cell lung cancer: A comprehensive review
    Daniel J. Tandberg, Betty Caroline Tong, Bradley G. Ackerson, Chris R. Kelsey · 2017 · Cancer
88. Implications of Nine Risk Prediction Models for Selecting Ever-Smokers for Computed Tomography Lung Cancer Screening
    Hormuzd A. Katki, Stephanie Ann Kovalchik, Lucia C. Petito, Li C. Cheung, Eric J. Jacobs, Ahmedin Jemal, Christine D. Berg, Anil K. Chaturvedi · 2018 · Annals of Internal Medicine
89. Stigma among patients with lung cancer: a patient-reported measurement model
    Heidi A. Hamann, Jamie S. Ostroff, Emily G. Marks, David E. Gerber, Joan H. Schiller, Simon J. Craddock Lee · 2013 · Psycho-Oncology
90. Predictive Accuracy of the Liverpool Lung Project Risk Model for Stratifying Patients for Computed Tomography Screening for Lung Cancer
    Olaide Y. Raji, S.W. Duffy, Olorunshola F. Agbaje, Stuart G. Baker, David C. Christiani, Adrian Cassidy, John K. Field · 2012 · Annals of Internal Medicine
91. Scanners and drillers: Characterizing expert visual search through volumetric images
    Trafton Drew, Melissa L.‐H. Võ, Alex Olwal, Francine L. Jacobson, Steven E. Seltzer, Jeremy M. Wolfe · 2013 · Journal of Vision
92. Attitudes towards lung cancer screening in socioeconomically deprived and heavy smoking communities: informing screening communication
    Samantha L. Quaife, Laura A.V. Marlow, Andy McEwen, Sam M. Janes, Jane Wardle · 2016 · Health Expectations
93. Lung cancer prediction using machine learning and advanced imaging techniques
    Timor Kadir, Fergus Vincent Gleeson · 2018 · Translational Lung Cancer Research
94. Leitlinie zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem (COPD)
    Claus Franz Vogelmeier, Roland Buhl, Otto Chris Burghuber, C.-P. Criée, Santiago Ewig, Jasminka Godnić‐Cvar, Sylvia Hartl, Felix J.F. Herth, Péter Kardos, Klaus Kenn et al. · 2018 · Pneumologie
95. Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time: a population-based study
    Ganfeng Luo, Yanting Zhang, Harriet Rumgay, Eileen Morgan, Oliver Langselius, Jérôme Vignat, Murielle Colombet, Freddie Bray · 2025 · The Lancet Respiratory Medicine
96. Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma
    Scafoglio, Claudio R., Villegas, Brendon, Abdelhady, Gihad, Bailey, Sean T., Liu, Jie, Shirali, Aditya S., Wallace, W. Dean, Magyar, Clara E., Grogan, Tristan R., Elashoff, David et al. · 2018 · Science Translational Medicine
97. Diagnosis of Lung Adenocarcinoma in Resected Specimens: Implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification
    William David Travis, Elisabeth M. Brambilla, Masayuki Noguchi, Andrew Gordon Nicholson, Kim R. Geisinger, Yasushi Yatabe, Yuichi Ishikawa, Ignacio Ivan Wistuba, Douglas B. Flieder, Wilbur A. Franklin et al. · 2012 · Archives of Pathology & Laboratory Medicine
98. A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non–Small Cell Lung Cancer and Serum DNA
    Akira Ooki, Zahra Maleki, Jun-Chieh James Tsay, Chandra M. V. Goparaju, Mariana Brait, Nitesh Turaga, Hae-Seong Nam, William N. Rom, Harvey Ira Pass, David Sidransky et al. · 2017 · Clinical Cancer Research
99. Can peritumoral radiomics increase the efficiency of the prediction for lymph node metastasis in clinical stage T1 lung adenocarcinoma on CT?
    Xiang Wang, Xingyu Zhao, Qiong Li, Wei Xia, Zhaohui Peng, Rui Zhang, Qingchu Li, Junming Jian, Wei Wang, Yuguo Tang et al. · 2019 · European Radiology
100. Artificial intelligence and radiomics in pulmonary nodule management: current status and future applications
     Sarim Ather, Timor Kadir, Fergus Vincent Gleeson · 2019 · Clinical Radiology